News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avila Therapeutics to Present at the 2011American Society of Hematology Annual Meeting



12/5/2011 6:28:14 AM

BEDFORD, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced today that two poster presentations on AVL-292, a highly selective Bruton’s tyrosine kinase (Btk) inhibitor being evaluated for the treatment of several hematologic cancers, will be presented at the 2011 American Society of Hematology (ASH) Annual meeting taking place on December 10-13, 2011 in San Diego, CA.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES